Keeping pace with generative AI in pharmaceutical and healthcare organisations
Increasingly, generative AI is transforming how that information is analysed, summarised and shared. According to 2026 research by the Copyright…
All articles by Fi Forrest
Fi Forrest
Senior writer at GMS, GlobalData. Previously feature writer at Just Style. TABBIE Honourable Mention winner. BA (Open) in English | BSc (Hons) in Geosciences. Also a graphic designer with certificates in Digital Marketing and Social Media. Lives by the beach.
-
-
Nine ways to ensure a reliable technology transfer
While these transfers are a normal part of business, navigating them requires a strategic approach to ensure smooth and efficient…
-
Live Biotherapeutic Products Whitepaper 2025
Growth in LBP production can be attributed to well-defined regulatory pathways in regions such as the US and EU, advancements…
-
New report showcases AI breakthroughs, diversity, and innovation for 2026
The brand-new edition of the 2026 Clinical Research Report examines key therapy areas and deep dives into the latest advances…
-
Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
Author: Manny Vazquez, Senior Director Clinical Data Strategy, Veeva The number of data points collected in clinical trials has tripled…
-
ESMO 2025: Data, decisions, and the future of oncology
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
-
Advanced bioconjugation strategies: New webinar tackles complex chemistry for targeted therapeutics
In the fast-paced environment of pharmaceutical innovation, bioconjugation has proved to be a cornerstone technology. By enabling the precise modification…
-
How AI and machine learning are transforming drug discovery
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
-
Natural history research is powering more effective decision-making in oncology clinical trials
In the US alone, over 7,000 different rare diseases affect more than 30 million people[i]. Many of these conditions are…
-
Challenges in filling for alum drug products: What does a CDMO need to successfully fill alum drug products?
What are Alum Products, and why are they challenging to fill? Alum products, commonly referring to aluminum-based adjuvants, play a…